An Integrated Analysis of C5AR2 Related to Malignant Properties and Immune Infiltration of Breast Cancer.
An Integrated Analysis of C5AR2 Related to Malignant Properties and Immune Infiltration of Breast Cancer.
复制标题
C5AR2与乳腺癌恶性特性及免疫浸润相关的综合分析
DOI:
10.3389/fonc.2021.736725
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Hu W
中科院分区:
文献类型:
--
作者:
Zhu Y;Wang X;Xu Y;Chen L;Ding P;Chen J;Hu W
Background C5AR2 (GPR77, C5L2) is the second receptor for C5a that is a potent protein generated by complement activation. C5AR2 can mediate its own signaling events and exert significant immunomodulatory effects through those events. However, research of C5AR2 in cancer is limited, and its function remains unclear in breast cancer. Methods The expression of C5AR2 and its correlations with prognosis, immune infiltration, tumor mutation burden (TMB), and microsatellite instability (MSI) in more than thirty types of cancers were described through GTEx, TCGA, PrognoScan, TIMER2.0, CCLE, HPA, and TISIDB database. C5AR2 showed strong relationships to those immune marker sets in breast cancer. Otherwise, CCK8 assay and Transwell assay were conducted to illustrate the role of C5AR2 in migration, invasion, and proliferation of breast cancer cells. Results Generally, C5AR2 expression differed across most cancerous and noncancerous tissues, and high C5AR2 expression significantly related to poor prognosis in BRCA, GBM, KICH, LAML, LGG, LIHC, PAAD, and STAD. Moreover, C5AR2 expression levels were dramatically correlated with recognized immune infiltration, especially the polarization of macrophages in breast cancer. Gene set enrichment analysis confirmed that C5AR2 participates in regulating multiple signaling pathways involved in tumorigenesis as well as tumor immunity. C5AR2 overexpression facilitated the functions such as migration, invasion, and proliferation in breast cancer cells, which is consistent with bioinformatics analysis. Conclusions C5AR2 is involved in immune infiltration and malignant characteristics of breast cancer, which may be a prospective biomarker for breast cancer.
登录
查看更多内容
影响因子:
4.6
作者:
Bonneville R;Krook MA;Kautto EA;Miya J;Wing MR;Chen HZ;Reeser JW;Yu L;Roychowdhury S
通讯作者:
Roychowdhury S
影响因子:
3.6
作者:
Ohno, M;Hirata, T;Takahashi, TA
通讯作者:
Takahashi, TA
DOI:
10.1126/science.aad1210
发表时间:
2016-06-17
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Arbore G;West EE;Spolski R;Robertson AAB;Klos A;Rheinheimer C;Dutow P;Woodruff TM;Yu ZX;O'Neill LA;Coll RC;Sher A;Leonard WJ;Köhl J;Monk P;Cooper MA;Arno M;Afzali B;Lachmann HJ;Cope AP;Mayer-Barber KD;Kemper C
通讯作者:
Kemper C
影响因子:
64.8
作者:
Chen, Nien-Jung;Mirtsos, Christine;Yeh, Wen-Chen
通讯作者:
Yeh, Wen-Chen
影响因子:
12.4
作者:
Ding, Peipei;Li, Ling;Hu, Weiguo
通讯作者:
Hu, Weiguo